Table 2 Changes during the 14-day antigen avoidance test
From: Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
Parameters | Antigen avoidance test | |
|---|---|---|
Positive | Negative | |
delta FVC %pred (%) | 2.4 ± 1.1 (n = 16) | 0.4 ± 0.9 (n = 20) |
delta Serum KL-6 (%) | − 6.5 ± 2.5 (n = 15) | 1.7 ± 2.1 (n = 23) |
delta White blood cell (%) | − 12.6 ± 2.9 (n = 17) | − 0.2 ± 3.3 (n = 23) |
delta C-reactive protein (mg/dL) | 0.02 ± 0.02 (n = 17) | − 0.08 ± 0.08 (n = 23) |